• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD8+ T 细胞在受到 CD27/CD70 共刺激后会产生趋化因子 CXCL10,以促进 CD8+效应 T 细胞池的生成。

CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool.

机构信息

Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

出版信息

J Immunol. 2013 Sep 15;191(6):3025-36. doi: 10.4049/jimmunol.1202222. Epub 2013 Aug 12.

DOI:10.4049/jimmunol.1202222
PMID:23940275
Abstract

Various cell types can produce the chemokine CXCL10 in response to IFN-γ stimulation. CXCL10 is generally viewed as a proinflammatory chemokine that promotes recruitment of CD8÷ and Th1-type CD4÷ effector T cells to infected or inflamed nonlymphoid tissues. We show that CXCL10 plays a role during CD8÷ T cell priming in the mouse. Genome-wide expression profiling revealed the Cxcl10 gene as a target of CD27/CD70 costimulation in newly activated CD8÷ T cells. CD27/CD70 costimulation is known to promote activated T cell survival, but CXCL10 did not affect survival or proliferation of primed CD8÷ T cells in vitro. Accordingly, CXCL10 could not fully rescue CD27 deficiency in mice infected with influenza virus. Rather, CXCL10 acted as chemoattractant for other activated CD8⁺ T cells. It signaled downstream of CD27 in a paracrine fashion to promote generation of the CD8÷ effector T cell pool in the Ag-draining lymph nodes. Consistently, CD8÷ T cells required expression of the CXCL10 receptor CXCR3 for their clonal expansion in a CD27/CD70-dependent peptide-immunization model. Our findings indicate that CXCL10, produced by primed CD8÷ T cells in response to CD27/CD70 costimulation, signals to other primed CD8⁺ T cells in the lymph node microenvironment to facilitate their participation in the CD8÷ effector T cell pool.

摘要

各种细胞类型均可在 IFN-γ 刺激下产生趋化因子 CXCL10。通常认为 CXCL10 是一种促炎趋化因子,可促进 CD8+和 Th1 型 CD4+效应 T 细胞向感染或炎症的非淋巴组织募集。我们表明,CXCL10 在小鼠 CD8+T 细胞的初始激活过程中发挥作用。全基因组表达谱分析显示,Cxcl10 基因是新激活的 CD8+T 细胞中 CD27/CD70 共刺激的靶基因。已知 CD27/CD70 共刺激可促进激活的 T 细胞存活,但 CXCL10 并未影响体外初始激活的 CD8+T 细胞的存活或增殖。因此,CXCL10 不能完全挽救感染流感病毒的 CD27 缺陷小鼠。相反,CXCL10 作为趋化因子吸引其他激活的 CD8+T 细胞。它以旁分泌方式在 CD27 下游信号转导,以促进 Ag 引流淋巴结中 CD8+效应 T 细胞池的生成。一致地,在 CD27/CD70 依赖性肽免疫模型中,CD8+T 细胞的克隆扩增需要 CXCL10 受体 CXCR3 的表达。我们的研究结果表明,在 CD27/CD70 共刺激下由初始激活的 CD8+T 细胞产生的 CXCL10 信号转导至淋巴结微环境中的其他初始激活的 CD8+T 细胞,以促进其参与 CD8+效应 T 细胞池。

相似文献

1
CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool.CD8+ T 细胞在受到 CD27/CD70 共刺激后会产生趋化因子 CXCL10,以促进 CD8+效应 T 细胞池的生成。
J Immunol. 2013 Sep 15;191(6):3025-36. doi: 10.4049/jimmunol.1202222. Epub 2013 Aug 12.
2
The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation.Pim 激酶通路在 CD27 共刺激后,为初始 CD8+ T 细胞的存活信号转导做出贡献。
J Immunol. 2010 Dec 1;185(11):6670-8. doi: 10.4049/jimmunol.1000159. Epub 2010 Nov 3.
3
Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.诱导人源单核细胞来源的树突状细胞表达 CD70 的最佳刺激条件,以及 CD70 在初始 CD4(+)T 细胞分化中的重要性。
Immunology. 2010 May;130(1):137-49. doi: 10.1111/j.1365-2567.2010.03220.x. Epub 2010 Feb 26.
4
CD70-driven costimulation induces survival or Fas-mediated apoptosis of T cells depending on antigenic load.CD70 驱动的共刺激诱导 T 细胞存活或 Fas 介导的凋亡,这取决于抗原负荷。
J Immunol. 2012 May 1;188(9):4256-67. doi: 10.4049/jimmunol.1102889. Epub 2012 Mar 26.
5
CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development.CD27与CD70的相互作用使初始CD4+ T细胞对白细胞介素-12诱导的Th1细胞发育敏感。
Int Immunol. 2007 Jun;19(6):713-8. doi: 10.1093/intimm/dxm033. Epub 2007 Jun 4.
6
CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes.CD27-CD27配体/CD70相互作用增强了同种抗原诱导的CD8+T淋巴细胞增殖和细胞溶解活性。
J Immunol. 1995 Apr 15;154(8):3686-95.
7
LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R.LFA-1 缺陷诱导的效应/记忆 CD8+T 细胞凋亡是通过 Bcl-2/Caspase 途径介导的,并与 CD27 和 IL-15R 的下调有关。
Mol Immunol. 2010 Aug;47(14):2411-21. doi: 10.1016/j.molimm.2010.02.005. Epub 2010 May 31.
8
The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants.共刺激分子 CD27 维持低抗原亲和力的克隆多样性 CD8(+) T 细胞应答,以保护机体免受病毒变异体的影响。
Immunity. 2011 Jul 22;35(1):97-108. doi: 10.1016/j.immuni.2011.04.020. Epub 2011 Jul 14.
9
T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.T细胞通过裂解细胞表面的CD27并阻止与携带CD70的抗原呈递细胞接触来进行竞争。
Eur J Immunol. 2015 Nov;45(11):3140-9. doi: 10.1002/eji.201545749. Epub 2015 Aug 3.
10
Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.共刺激配体CD70在稳态树突状细胞上的表达打破了CD8⁺T细胞的耐受性并允许有效的免疫反应。
Immunity. 2008 Dec 19;29(6):934-46. doi: 10.1016/j.immuni.2008.10.009. Epub 2008 Dec 8.

引用本文的文献

1
Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy.肿瘤内在的干扰素信号传导驱动胰腺癌对靶向肿瘤黏蛋白1的嵌合抗原受体T细胞疗法产生抗性。
Front Immunol. 2025 Aug 8;16:1618415. doi: 10.3389/fimmu.2025.1618415. eCollection 2025.
2
Mechanisms of autoimmune-mediated paraneoplastic syndromes: immune tolerance and disease pathogenesis.自身免疫介导的副肿瘤综合征的机制:免疫耐受与疾病发病机制。
Front Immunol. 2025 May 9;16:1608934. doi: 10.3389/fimmu.2025.1608934. eCollection 2025.
3
Decitabine promotes the differentiation of poorly differentiated gastric cancer cells and enhances the sensitivity of NK cell cytotoxicity via TNF-α.
地西他滨促进低分化胃癌细胞的分化,并通过肿瘤坏死因子-α增强自然杀伤细胞的细胞毒性敏感性。
Sci Rep. 2025 Apr 16;15(1):13119. doi: 10.1038/s41598-025-95741-0.
4
Integrated transcriptomic profiling reveals a STING-mediated Type II Interferon signature in SOD1-mutant amyotrophic lateral sclerosis models.整合转录组分析揭示了SOD1突变型肌萎缩侧索硬化症模型中由STING介导的II型干扰素特征。
Commun Biol. 2025 Mar 2;8(1):347. doi: 10.1038/s42003-025-07790-w.
5
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.XCL1-XCR1轴支持肠道组织驻留和抗肿瘤免疫。
J Exp Med. 2025 Mar 3;222(2). doi: 10.1084/jem.20240776. Epub 2025 Jan 22.
6
The role of IFN-γ/CXCL10 axis in Mycoplasma pneumonia infection.IFN-γ/CXCL10轴在支原体肺炎感染中的作用。
Sci Rep. 2025 Jan 21;15(1):2671. doi: 10.1038/s41598-024-84969-x.
7
Versatile tissue-injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics.能够实现生物活性蛋白治疗药物延长水解释放的多功能可注射组织水凝胶。
Bioeng Transl Med. 2024 Apr 15;9(5):e10668. doi: 10.1002/btm2.10668. eCollection 2024 Sep.
8
Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway.脂质纳米颗粒作为诺如病毒VLP疫苗的佐剂,通过TLR9和I型干扰素依赖性途径增强细胞免疫和体液免疫反应。
J Virol. 2024 Dec 17;98(12):e0169924. doi: 10.1128/jvi.01699-24. Epub 2024 Nov 4.
9
Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.一种旨在阻断急性髓系白血病中适应性瓦伯格效应的基于竞争性营养物质的T细胞免疫疗法的开发。
Biomedicines. 2024 Oct 3;12(10):2250. doi: 10.3390/biomedicines12102250.
10
The differential proteomic response to ischemic stroke in appalachian subjects treated with mechanical thrombectomy.阿巴拉契亚地区接受机械取栓治疗的缺血性卒中患者的差异蛋白质组学反应。
J Neuroinflammation. 2024 Aug 17;21(1):205. doi: 10.1186/s12974-024-03201-9.